14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
PMI vs MTG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, MGIC Investment Corp. (MTG) is the stronger overall head-to-head candidate over Picard Medical, Inc. (PMI) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PMI carries a Unified Composite Score of 48.4/100 (HOLD) at $6.30 (N/M Forward P/E, -248.1% operating margin), whereas MTG carries 34.5/100 (SELL) at $26.69 (7.7x Forward P/E, 76.1% operating margin).
Composite vs. Pillar Nuance: While PMI currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. MTG 34.5/100 SELL), MTG captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (76.1% vs. -248.1% operating margin) and revenue trajectory (-1.8% vs. +38.6% YoY).
Technical & Structure Timing Caution: PMI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 42.1); meanwhile MTG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PMI vs MTG. Trailing 12-month operating profitability (PMI -248.1% vs MTG 76.1%) and valuation multiples (PMI N/M vs MTG 7.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $17.1M market capitalization and -248.1% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
MTG Moat ProfileHigh-Margin Pricing Power Moat
Insurance - Specialty Operator
Competes within the Insurance - Specialty value chain with $5.4B market capitalization and 76.1% operating margin.
OpEx & R&D Reinvestment15.6% of Rev ($186M)
90D Engineering Disclosures0 Published
Investor FAQ PMI vs MTG Key Questions & Quantitative Answers
As of Nov 19, 2026, MGIC Investment Corp. (MTG) is the stronger overall head-to-head candidate over Picard Medical, Inc. (PMI) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PMI carries a Unified Composite Score of 48.4/100 (HOLD) at $6.30 (N/M Forward P/E, -248.1% operating margin), whereas MTG carries 34.5/100 (SELL) at $26.69 (7.7x Forward P/E, 76.1% operating margin). Composite vs. Pillar Nuance: While PMI currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. MTG 34.5/100 SELL), MTG captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (76.1% vs. -248.1% operating margin) and revenue trajectory (-1.8% vs. +38.6% YoY). Technical & Structure Timing Caution: PMI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 42.1); meanwhile MTG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MTG leads the Growth & Scale pillar: PMI posts +38.6% YoY revenue growth and +0.0% YoY earnings growth on $6.3M TTM revenue (18.6% gross margin, -248.1% operating margin), compared with MTG at -1.8% YoY revenue growth and +2.4% YoY earnings growth on $1.19B TTM revenue (91.7% gross margin, 76.1% operating margin). On trailing 12-month operating scale, PMI generates $6.3M in USD-normalized revenue versus $1.19B for MTG. In operating R&D and SG&A reinvestment, PMI deploys N/A (0 90-day corporate R&D disclosures) versus 15.6% of Rev ($186M) (0 disclosures) for MTG.
MTG screens cheaper on headline valuation multiples. PMI trades at N/M Forward P/E, 2.9x Trailing P/E, N/M PEG, and 3.2x EV/Revenue (unreported FCF margin), whereas MTG trades at 7.7x Forward P/E, 8.4x Trailing P/E, 0.40x PEG, and 4.5x EV/Revenue (76.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PMI (0.0% ROE) versus MTG (13.8% ROE) capital efficiency.
In options market volatility and institutional positioning, PMI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (54.06β · 134% Vol realized risk). By comparison, MTG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 25% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.